Click for best price
Diabetes Associated Ophthalmic Treatment Market Size, Share 2023
Diabetic eye disease is a group of eye problems that can affect people with diabetes. These conditions include diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. An increase in the incidence of diabetes due to aging, obesity, and an unhealthy lifestyle is one of the factors contributing to the growth of the market for diabetes-associated ophthalmic.
This report aims to provide a comprehensive presentation of the global market for Diabetes Associated Ophthalmic Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Associated Ophthalmic Treatment. This report contains market size and forecasts of Diabetes Associated Ophthalmic Treatment in global, including the following market information:
Global Diabetes Associated Ophthalmic Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Associated Ophthalmic Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Dry Eye Syndrome Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Associated Ophthalmic Treatment include Alcon, Johnson & Johnson Services, Inc., Bausch Health, F. Hoffmann-La Roche Ltd, Allergan, Bayer AG, Santen Pharmaceutical Co. Ltd., Novartis AG and Pfizer, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Associated Ophthalmic Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Associated Ophthalmic Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, by Type, 2022 (%)
Dry Eye Syndrome
Glaucoma
Eye Allergy & Infection
Diabetic Retinopathy
Diabetic associated Macular Degeneration
Uveitis
Cataract
Diabetic Macular Edema
Others
Global Diabetes Associated Ophthalmic Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ophthalmic Centers
Ambulatory Surgical Centers
Others
Global Diabetes Associated Ophthalmic Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Associated Ophthalmic Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Associated Ophthalmic Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alcon
Johnson & Johnson Services, Inc.
Bausch Health
F. Hoffmann-La Roche Ltd
Allergan
Bayer AG
Santen Pharmaceutical Co. Ltd.
Novartis AG
Pfizer, Inc.
Genentech, Inc.
Carl Zeiss Meditec
Lumenis
Ellex Medical Lasers Ltd.
IRIDEX Corp.
Topcon Corp.
Abbott Medical Optics
Quantel
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Associated Ophthalmic Treatment, market overview.
Chapter 2: Global Diabetes Associated Ophthalmic Treatment market size in revenue.
Chapter 3: Detailed analysis of Diabetes Associated Ophthalmic Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Associated Ophthalmic Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Diabetes Associated Ophthalmic Treatment Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
103 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetes Associated Ophthalmic Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Associated Ophthalmic Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Associated Ophthalmic Treatment Overall Market Size
2.1 Global Diabetes Associated Ophthalmic Treatment Market Size: 2022 VS 2029
2.2 Global Diabetes Associated Ophthalmic Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Associated Ophthalmic Treatment Players in Global Market
3.2 Top Global Diabetes Associated Ophthalmic Treatment Companies Ranked by Revenue
3.3 Global Diabetes Associated Ophthalmic Treatment Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Associated Ophthalmic Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diabetes Associated Ophthalmic Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Associated Ophthalmic Treatment Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Associated Ophthalmic Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Associated Ophthalmic Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Associated Ophthalmic Treatment Market Size Markets, 2022 & 2029
4.1.2 Dry Eye Syndrome
4.1.3 Glaucoma
4.1.4 Eye Allergy & Infection
4.1.5 Diabetic Retinopathy
4.1.6 Diabetic associated Macular Degeneration
4.1.7 Uveitis
4.1.8 Cataract
4.1.9 Diabetic Macular Edema
4.1.10 Others
4.2 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue & Forecasts
4.2.1 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue, 2018-2023
4.2.2 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue, 2024-2029
4.2.3 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Associated Ophthalmic Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Ophthalmic Centers
5.1.4 Ambulatory Surgical Centers
5.1.5 Others
5.2 By Application - Global Diabetes Associated Ophthalmic Treatment Revenue & Forecasts
5.2.1 By Application - Global Diabetes Associated Ophthalmic Treatment Revenue, 2018-2023
5.2.2 By Application - Global Diabetes Associated Ophthalmic Treatment Revenue, 2024-2029
5.2.3 By Application - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Diabetes Associated Ophthalmic Treatment Market Size, 2022 & 2029
6.2 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue & Forecasts
6.2.1 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue, 2018-2023
6.2.2 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue, 2024-2029
6.2.3 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Diabetes Associated Ophthalmic Treatment Revenue, 2018-2029
6.3.2 US Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.3.3 Canada Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.3.4 Mexico Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue, 2018-2029
6.4.2 Germany Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.4.3 France Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.4.4 U.K. Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.4.5 Italy Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.4.6 Russia Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.4.8 Benelux Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue, 2018-2029
6.5.2 China Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.5.3 Japan Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.5.4 South Korea Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.5.6 India Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Diabetes Associated Ophthalmic Treatment Revenue, 2018-2029
6.6.2 Brazil Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.6.3 Argentina Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue, 2018-2029
6.7.2 Turkey Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.7.3 Israel Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
6.7.5 UAE Diabetes Associated Ophthalmic Treatment Market Size, 2018-2029
7 Diabetes Associated Ophthalmic Treatment Companies Profiles
7.1 Alcon
7.1.1 Alcon Company Summary
7.1.2 Alcon Business Overview
7.1.3 Alcon Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.1.4 Alcon Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.1.5 Alcon Key News & Latest Developments
7.2 Johnson & Johnson Services, Inc.
7.2.1 Johnson & Johnson Services, Inc. Company Summary
7.2.2 Johnson & Johnson Services, Inc. Business Overview
7.2.3 Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.2.4 Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Services, Inc. Key News & Latest Developments
7.3 Bausch Health
7.3.1 Bausch Health Company Summary
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.3.4 Bausch Health Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.3.5 Bausch Health Key News & Latest Developments
7.4 F. Hoffmann-La Roche Ltd
7.4.1 F. Hoffmann-La Roche Ltd Company Summary
7.4.2 F. Hoffmann-La Roche Ltd Business Overview
7.4.3 F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.4.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.5.4 Allergan Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.5.5 Allergan Key News & Latest Developments
7.6 Bayer AG
7.6.1 Bayer AG Company Summary
7.6.2 Bayer AG Business Overview
7.6.3 Bayer AG Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.6.4 Bayer AG Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.6.5 Bayer AG Key News & Latest Developments
7.7 Santen Pharmaceutical Co. Ltd.
7.7.1 Santen Pharmaceutical Co. Ltd. Company Summary
7.7.2 Santen Pharmaceutical Co. Ltd. Business Overview
7.7.3 Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.7.4 Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.7.5 Santen Pharmaceutical Co. Ltd. Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.8.4 Novartis AG Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 Pfizer, Inc.
7.9.1 Pfizer, Inc. Company Summary
7.9.2 Pfizer, Inc. Business Overview
7.9.3 Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.9.4 Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.9.5 Pfizer, Inc. Key News & Latest Developments
7.10 Genentech, Inc.
7.10.1 Genentech, Inc. Company Summary
7.10.2 Genentech, Inc. Business Overview
7.10.3 Genentech, Inc. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.10.4 Genentech, Inc. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.10.5 Genentech, Inc. Key News & Latest Developments
7.11 Carl Zeiss Meditec
7.11.1 Carl Zeiss Meditec Company Summary
7.11.2 Carl Zeiss Meditec Business Overview
7.11.3 Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.11.4 Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.11.5 Carl Zeiss Meditec Key News & Latest Developments
7.12 Lumenis
7.12.1 Lumenis Company Summary
7.12.2 Lumenis Business Overview
7.12.3 Lumenis Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.12.4 Lumenis Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.12.5 Lumenis Key News & Latest Developments
7.13 Ellex Medical Lasers Ltd.
7.13.1 Ellex Medical Lasers Ltd. Company Summary
7.13.2 Ellex Medical Lasers Ltd. Business Overview
7.13.3 Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.13.4 Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.13.5 Ellex Medical Lasers Ltd. Key News & Latest Developments
7.14 IRIDEX Corp.
7.14.1 IRIDEX Corp. Company Summary
7.14.2 IRIDEX Corp. Business Overview
7.14.3 IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.14.4 IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.14.5 IRIDEX Corp. Key News & Latest Developments
7.15 Topcon Corp.
7.15.1 Topcon Corp. Company Summary
7.15.2 Topcon Corp. Business Overview
7.15.3 Topcon Corp. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.15.4 Topcon Corp. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.15.5 Topcon Corp. Key News & Latest Developments
7.16 Abbott Medical Optics
7.16.1 Abbott Medical Optics Company Summary
7.16.2 Abbott Medical Optics Business Overview
7.16.3 Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.16.4 Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.16.5 Abbott Medical Optics Key News & Latest Developments
7.17 Quantel
7.17.1 Quantel Company Summary
7.17.2 Quantel Business Overview
7.17.3 Quantel Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.17.4 Quantel Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2018-2023)
7.17.5 Quantel Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetes Associated Ophthalmic Treatment Market Opportunities & Trends in Global Market
Table 2. Diabetes Associated Ophthalmic Treatment Market Drivers in Global Market
Table 3. Diabetes Associated Ophthalmic Treatment Market Restraints in Global Market
Table 4. Key Players of Diabetes Associated Ophthalmic Treatment in Global Market
Table 5. Top Diabetes Associated Ophthalmic Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diabetes Associated Ophthalmic Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diabetes Associated Ophthalmic Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diabetes Associated Ophthalmic Treatment Product Type
Table 9. List of Global Tier 1 Diabetes Associated Ophthalmic Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Associated Ophthalmic Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Alcon Company Summary
Table 31. Alcon Diabetes Associated Ophthalmic Treatment Product Offerings
Table 32. Alcon Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Alcon Key News & Latest Developments
Table 34. Johnson & Johnson Services, Inc. Company Summary
Table 35. Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 36. Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Services, Inc. Key News & Latest Developments
Table 38. Bausch Health Company Summary
Table 39. Bausch Health Diabetes Associated Ophthalmic Treatment Product Offerings
Table 40. Bausch Health Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Bausch Health Key News & Latest Developments
Table 42. F. Hoffmann-La Roche Ltd Company Summary
Table 43. F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Product Offerings
Table 44. F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 46. Allergan Company Summary
Table 47. Allergan Diabetes Associated Ophthalmic Treatment Product Offerings
Table 48. Allergan Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Allergan Key News & Latest Developments
Table 50. Bayer AG Company Summary
Table 51. Bayer AG Diabetes Associated Ophthalmic Treatment Product Offerings
Table 52. Bayer AG Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Bayer AG Key News & Latest Developments
Table 54. Santen Pharmaceutical Co. Ltd. Company Summary
Table 55. Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 56. Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Santen Pharmaceutical Co. Ltd. Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Diabetes Associated Ophthalmic Treatment Product Offerings
Table 60. Novartis AG Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis AG Key News & Latest Developments
Table 62. Pfizer, Inc. Company Summary
Table 63. Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 64. Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer, Inc. Key News & Latest Developments
Table 66. Genentech, Inc. Company Summary
Table 67. Genentech, Inc. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 68. Genentech, Inc. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Genentech, Inc. Key News & Latest Developments
Table 70. Carl Zeiss Meditec Company Summary
Table 71. Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Product Offerings
Table 72. Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Carl Zeiss Meditec Key News & Latest Developments
Table 74. Lumenis Company Summary
Table 75. Lumenis Diabetes Associated Ophthalmic Treatment Product Offerings
Table 76. Lumenis Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Lumenis Key News & Latest Developments
Table 78. Ellex Medical Lasers Ltd. Company Summary
Table 79. Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 80. Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. Ellex Medical Lasers Ltd. Key News & Latest Developments
Table 82. IRIDEX Corp. Company Summary
Table 83. IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 84. IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 85. IRIDEX Corp. Key News & Latest Developments
Table 86. Topcon Corp. Company Summary
Table 87. Topcon Corp. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 88. Topcon Corp. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 89. Topcon Corp. Key News & Latest Developments
Table 90. Abbott Medical Optics Company Summary
Table 91. Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Product Offerings
Table 92. Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 93. Abbott Medical Optics Key News & Latest Developments
Table 94. Quantel Company Summary
Table 95. Quantel Diabetes Associated Ophthalmic Treatment Product Offerings
Table 96. Quantel Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn) & (2018-2023)
Table 97. Quantel Key News & Latest Developments
List of Figures
Figure 1. Diabetes Associated Ophthalmic Treatment Segment by Type in 2022
Figure 2. Diabetes Associated Ophthalmic Treatment Segment by Application in 2022
Figure 3. Global Diabetes Associated Ophthalmic Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetes Associated Ophthalmic Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Diabetes Associated Ophthalmic Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Associated Ophthalmic Treatment Revenue in 2022
Figure 8. By Type - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
Figure 16. US Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
Figure 28. China Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Alcon Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bausch Health Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Allergan Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bayer AG Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis AG Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Genentech, Inc. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Lumenis Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Topcon Corp. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Quantel Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
